Abstract:SESSION TITLE: Chest Infections II SESSION TYPE: Case Report Poster PRESENTED ON: Sunday, April 17, 2016 at 11:45 AM - 12:45 PM INTRODUCTION: Septic shock is systemic inflammatory responses caused by interaction between the host immune system and microorganisms with high mortality. The most common sources of infection are respiratory and abdomina. And the most common pathogens of pneumonia that lead to septic shock are gram negative bacilli early, goal-directed resuscitation for septic shock and China's severe sepsis/septic shock treatment guidelines of 2014 was published which gives a great help for the clinical treatment of septic shock. CASE PRESENTATION: A 38-year-old women, who had a fever for 7days, and dyspnea for 2days. Her past medical history was hypothyroidism. We had the diagnoses of respiratory failure of type I, severe pneumonia. Our immediate empiric antimicrobial therapy was ertapenem combined levofloxacin. On the third day of hospitalization, her dyspnea exacerbated with the temperature of 40℃, BP 77/47mmHg. She was transferred to the RICU and was given fluid resuscitation, vasopressors intubated and mechanically ventilated, but she remained persistently hypotensive, oxygen saturation could’t be messured.we completed ECMO by the bed, the shock was gradually corrected. We adjusted the antibiotics according to the sputum culture. and did some support treatments. Then cerebral hemorrhage and subarachnoid hemorrhage, bloodstream infection, puncture wound infection occured. She finally died in septic shock. DISCUSSION: The patient’s septic shock was caused by severe pneumonia. We had corrected the shock and adjusted antibiotic therapy according to the result of drug sensitive test. Then bloodstream infection and puncture wound infection presented, contributed to the disease progression and the death. With increased drug resistance of these bacteria, antibiotic therapy is more and more difficult. The antibiotics we used are broad spectrum and sensitive to the bacteria, but the patient had a poor therapeutic outcome. We think it may have a relationship with the bad base state of the patient and more complications. In the later stage of the treatment, the patient had cerebral hemorrhage and subarachnoid hemorrhage, the reason might be the low level of platelet caused by bone marrow inhibition. So we should positively complement the blood products in the treatment of septic shock and make the amount of platelet reach the standard. CONCLUSIONS: Due to the high mortality of septic shock, it is important to have a comprehensive therapy, especially in initial empiric antibiotic therapy which should have a universal coverage of the pathogenic bacteria and the effective prevention of the complications. Reference #1: China's severe sepsis/septic shock treatment guidelines. Chin Crit Care Med, June 2015, Vol.27, No.6. Reference #2: Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012. Intensive Care Med (2013) 39:165-228. Reference #3: Qiang Chen, Xiaozhen Jiang, Guagju Zhao.ect. Mortality and risk factors of septic shock in 159 patients in emergency intensive care unit. J Med Res, Feb 2012, Vol. 41 No. 2. DISCLOSURE: The following authors have nothing to disclose: Xiaoyan Sun, Bei He, Ning Shen, Yan Ding, Chun Chang No Product/Research Disclosure Information

Carbapenem is not always the best choice in the treatment of septic shock

Severe Pneumonia and Septic Shock

Knowledge of and Compliance with Surviving Sepsis Campaign Guidelines among Anesthesiologists: A Nationwide Survey in China

Association of medical care capacity and the patient mortality of septic shock: a cross-sectional study

Association between quality control and outcomes of septic shock caused by intestinal perforation in China: a cross-sectional study

Effectiveness of Anisodamine for the Treatment of Critically Ill Patients with Septic Shock (acidosis Study): Study Protocol for Randomized Controlled Trial

A Real-World Study Comparing Various Antimicrobial Regimens for Bloodstream Infections Caused by Carbapenem-Resistant Gram-Negative Bacilli in a Tertiary Hospital, Shanghai, China, from 2010 to 2017

The Prevalence, Risk Factors, and Outcomes of Sepsis in Critically Ill Patients in China: A Multicenter Prospective Cohort Study

Clinical study on patients with gastrointestinal related acute abdomen complicated with septic shock

Application of Chinese Medicine in the Management of Critical Conditions: A Review on Sepsis

Thymosin Alpha(1)- and Ulinastatin-Based Immunomodulatory Strategy for Sepsis Arising from Intra-Abdominal Infection Due to Carbapenem-Resistant Bacteria

Do the observational studies using propensity score analysis agree with randomized controlled trials in the area of sepsis?

An Email-Based Survey of Treatment Strategies in Children with Septic Shock in China

Effectiveness of β-blockers in improving 28-day mortality in septic shock: insights from subgroup analysis and retrospective observational study

Systematic Review on the Effects of Prompt Antibiotic Treatment on Survival in Septic Shock and Sepsis Patients in Different Hospital Settings

Study of Empiric Antibiotic Prescription Patterns and Microbiological Isolates in Hemodynamically Stable and Unstable ICU Patients With Community-Acquired Sepsis

Comparison of Empirical Therapy with Cefoperazone/sulbactam or a Carbapenem for Bloodstream Infections Due to ESBL-producing Enterobacteriaceae.

Adequacy of probabilistic prehospital antibiotic therapy for septic shock

Comparative Efficacy of Tonic Chinese Herbal Injections for Treating Sepsis or Septic Shock: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Controlled Trials

Epidemiology and Outcome of Severe Sepsis and Septic Shock in Intensive Care Units in Mainland China.

Epidemiological Study of Sepsis in China